Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Isolated (hypoxic) hepatic perfusion with high-dose chemotherapy in patients with unresectable liver metastases of uveal melanoma: results from two experienced centres.
de Leede EM, Burgmans MC, Kapiteijn E, Luyten GP, Jager MJ, Tijl FG, Hartgrink HH, Grünhagen DJ, Rothbarth J, van de Velde CJ, Verhoef C, Vahrmeijer AL. de Leede EM, et al. Among authors: burgmans mc. Melanoma Res. 2016 Dec;26(6):588-594. doi: 10.1097/CMR.0000000000000286. Melanoma Res. 2016. PMID: 27513071
Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.
de Leede EM, Burgmans MC, Meijer TS, Martini CH, Tijl FGJ, Vuyk J, van Erkel AR, van der Velde CJH, Kapiteijn E, Vahrmeijer AL. de Leede EM, et al. Among authors: burgmans mc. Cardiovasc Intervent Radiol. 2017 Aug;40(8):1196-1205. doi: 10.1007/s00270-017-1630-4. Epub 2017 Apr 27. Cardiovasc Intervent Radiol. 2017. PMID: 28451811 Free PMC article. Clinical Trial.
Erratum to: Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.
de Leede EM, Burgmans MC, Meijer TS, Martini CH, Tijl FGJ, Vuyk J, van Erkel AR, van der Velde CJH, Kapiteijn E, Vahrmeijer AL. de Leede EM, et al. Among authors: burgmans mc. Cardiovasc Intervent Radiol. 2017 Dec;40(12):1966. doi: 10.1007/s00270-017-1766-2. Cardiovasc Intervent Radiol. 2017. PMID: 28840267 Free PMC article. No abstract available.
Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.
Puijk RS, Ruarus AH, Vroomen LGPH, van Tilborg AAJM, Scheffer HJ, Nielsen K, de Jong MC, de Vries JJJ, Zonderhuis BM, Eker HH, Kazemier G, Verheul H, van der Meijs BB, van Dam L, Sorgedrager N, Coupé VMH, van den Tol PMP, Meijerink MR; COLLISION Trial Group. Puijk RS, et al. BMC Cancer. 2018 Aug 15;18(1):821. doi: 10.1186/s12885-018-4716-8. BMC Cancer. 2018. PMID: 30111304 Free PMC article. Clinical Trial.
Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial.
Meijer TS, Burgmans MC, Fiocco M, de Geus-Oei LF, Kapiteijn E, de Leede EM, Martini CH, van der Meer RW, Tijl FGJ, Vahrmeijer AL. Meijer TS, et al. Among authors: burgmans mc. Cardiovasc Intervent Radiol. 2019 Jun;42(6):841-852. doi: 10.1007/s00270-019-02177-x. Epub 2019 Feb 14. Cardiovasc Intervent Radiol. 2019. PMID: 30767147 Free PMC article. Clinical Trial.
Quantitative margin assessment of radiofrequency ablation of a solitary colorectal hepatic metastasis using MIRADA RTx on CT scans: a feasibility study.
Sibinga Mulder BG, Hendriks P, Baetens TR, van Erkel AR, van Rijswijk CSP, van der Meer RW, van de Velde CJH, Vahrmeijer AL, Mieog JSD, Burgmans MC. Sibinga Mulder BG, et al. Among authors: burgmans mc. BMC Med Imaging. 2019 Aug 20;19(1):71. doi: 10.1186/s12880-019-0360-2. BMC Med Imaging. 2019. PMID: 31429708 Free PMC article.
79 results